Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	77	54	48	261	180	66
Market Cap Growth	151.14%	13.34%	-81.76%	44.83%	173.65%	6.09%
Enterprise Value	66	49	35	206	139	40
PE Ratio	-	-1.04	-0.76	-4.60	-7.79	-2.66
PS Ratio	1132.35	523.05	247.57	972.14	168.28	38.49
PB Ratio	-7.14	-4.13	-2.44	8.76	5.09	3.49
P/FCF Ratio	-1.83	-1.13	-0.83	-9.90	-10.87	-3.08
P/OCF Ratio	-1.83	-1.13	-0.83	-9.90	-10.87	-3.08
EV/Sales Ratio	967.05	475.21	184.71	767.91	130.14	23.22
EV/EBITDA Ratio	-1.18	-0.94	-0.57	-3.63	-6.03	-1.60
EV/EBIT Ratio	-1.18	-0.94	-0.57	-3.63	-6.03	-1.60
EV/FCF Ratio	-1.55	-1.03	-0.62	-7.82	-8.41	-1.86
Quick Ratio	0.51	0.27	0.37	2.11	5.65	3.22
Current Ratio	0.54	0.29	0.41	2.15	5.90	3.32
Asset Turnover	0.01	0.02	0.01	0.00	0.03	0.10
Return on Equity (ROE)	319.00%	267.50%	-3651.50%	-120.10%	-89.80%	-250.90%
Return on Assets (ROA)	-749.80%	-950.00%	-227.90%	-92.80%	-70.40%	-138.20%
Return on Capital (ROIC)	439.15%	399.69%	299.40%	-190.69%	-65.58%	-131.85%
Earnings Yield	-67.95%	-96.24%	-131.75%	-21.75%	-12.83%	-37.59%
FCF Yield	-51.99%	-88.33%	-121.08%	-10.10%	-9.20%	-32.51%
Buyback Yield / Dilution	-180.28%	-112.13%	-16.21%	-36.18%	-58.14%	-23.64%
Total Shareholder Return	-180.28%	-112.13%	-16.21%	-36.18%	-58.14%	-23.64%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).